C	FDA	C54450	Patient Problem Codes FDA CDRH	C34620	2687	FOREIGN BODY IN PATIENT		An occurrence where any object originating inside or outside the body is not in it's physiological or intended location. For example, a tooth or bone fragment being swallowed; or device's components or fragments being found in the body away from where they were implanted.		C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50436	2261	SEIZURES, ABSENCE	PETIT-MAL SEIZURES|SEIZURES, PETIT-MAL	The seizure seen in absence epilepsy, consisting of a sudden momentary break in consciousness of thought or activity, often accompanied by automatisms or clonic movements, especially of the eyelids.	Generalized seizure that manifests in a form of a brief episode of impairment of consciousness with or without accompanying motor phenomena such as clonic-tonic components, automatisms, or autonomic components.	C2962	2063	SEIZURES
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50460	1703	SHOCK, ANAPHYLACTIC	ANAPHYLACTIC SHOCK|ANAPHYLAXIS	Systemic anaphylaxis is the most dramatic example of an immediate hypersensitivity reaction; is uncommon and unexpected in nature and occasionally results in a fatal outcome.	An acute inflammatory reaction resulting from the release of histamine and histamine-like substances from mast cells, causing a hypersensitivity immune response. Clinically, it presents with breathing difficulty, dizziness, hypotension, cyanosis and loss of consciousness, and may lead to death.	C35016	2072	SHOCK
C	FDA	C54451	Medical Device Problem Codes FDA CDRH	C63015	2284	DEVICE DAMAGED PRIOR TO USE	DAMAGE, INTERNAL/EXTERNAL|DAMAGED ITEM|ITEM DAMAGED PRIOR TO USE			C63020	2897	COMPONENT OR ACCESSORY INCOMPATIBILITY
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C54028	3291	EVALUATION METHOD				C62596		
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91896	10	ACTUAL DEVICE EVALUATED				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91897	3263	ACTUAL DEVICE NOT EVALUATED				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91898	3261	ACOUSTIC ENERGY TESTING		Testing the device for its response to variations in air pressure produced by the vibration of an object.		C91963	26	MECHANICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91899	3262	ACOUSTIC NOISE TESTING		Testing the device's response to variations in air pressure for detecting any unwanted or unintentional sound.		C91898	3261	ACOUSTIC ENERGY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91900	3264	AGENT CONTAMINATION TESTING		Testing the device for the presence of chemicals or other agents that do not belong on the device (contamination).		C91912	3277	CONTAMINATION TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91901	3265	AGGLUTINATION TESTING		Evaluating the device for characteristics that may cause blood to clot.		C91938	3298	HEMATOLOGIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91902	3266	ASSEMBLY AND PACKAGING REVIEW		Performing a review of the assembly and packaging processes and records for a specific device or lot that may have contributed to problems with the device.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91903	3267	BIOASSAY EVALUATION		Measuring the effects of a substance on a living organism. Bioassays may be qualitative or quantitative. Qualitative bioassays are used for assessing the physical effects of a substance that may not be quantified, such as abnormal development or deformity.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91904	3268	BIOCOMPATIBILITY TESTING		Testing the device to determine if it elicits an undesirable local or systemic biological effect in the cells or tissues of the recipient of that device. This includes testing the device for its toxicity to cells.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91905	3269	BIOLOGIC EVALUATION				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91906	3270	CARCINOGENIC TESTING		Testing the device's ability to promote cancer or facilitate its propagation.		C91934	3294	GENOTOXIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91907	3271	CELL EVALUATION		Evaluating a device's characteristics that may affect cells.		C92015	3364	TISSUE ENGINEERING EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91908	3274	COMPLEMENT ACTIVATION TESTING		Evaluating a device's ability to activate the process of clearing pathogens from a organism.		C91938	3298	HEMATOLOGIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91909	3275	COMPOSITION TESTING		Testing the device to determine if the correct combination of materials or elements is present (e.g., the composition of the materials of a capacitor).		C91961	3318	MATERIALS AND CHEMISTRY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91910	28	COMPRESSION TESTING		Testing the device for problems that can occur as the result of excessive stress or pressure applied to the device resulting in its compaction (decrease of volume).		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91911	3276	CONDUCTED EMISSIONS TESTING		Testing the ability of a device's conducted emissions to cause another device to fail (i.e. electromagnetic disturbance for which the energy is transferred via one or more conductors).		C91925	3289	EMISSIONS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91912	3277	CONTAMINATION TESTING		Testing the device to detect the presence of any substance that can cause infection or fever.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91913	3278	CREEP (STRENGTH) TESTING		Testing the device's ability to withstand a constant tensile load at elevated temperatures. (Creep is the form of plastic deformation that takes place in steel held for long periods at high temperature.)		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91914	3279	CURRENT LEAKAGE TESTING		Testing to detect the amount of electricity leakage from the device.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91915	3280	DATA VALIDATION		Ensuring that data used and generated by a program is correct.		C91993	22	SOFTWARE EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91916	3281	DEGRADATION/CORROSION/EROSION TESTING		Testing the device for its corrosive behavior to specific environments or materials. Tests may include polarization, potentiostatic, galvanic, critical pitting/crevice temperature, and inhibitor testing.		C91961	3318	MATERIALS AND CHEMISTRY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91917	3282	DESIGN VALIDATION		Validating that the device meets the user's needs and intended uses.		C91995	3347	SOFTWARE VALIDATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91918	3283	ELASTICITY TESTING		Testing the device's ability to recover its size and shape after being deformed during the test.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91919	23	ELECTRICAL EVALUATION				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91920	3284	ELECTRICAL FAST BURST TESTING		Testing the device for failures related to interference voltage tests which are bursts of electrical pulses (e.g. when a switch is turned on or off or the device is plugged in or out).		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91921	3285	ELECTRICAL SLOW FLUCTUATION TESTING		Testing the device to detect malfunctions caused by a sudden reduction of the voltage at a particular point in an electricity supply system below a specified "dip" threshold followed by its recovery after a brief interval.		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91922	3286	ELECTROMAGNETIC COMPATIBILITY (EMC) EVALUATION		Evaluating a device to detect malfunctions caused by electromagnetic interference (unwanted disturbances from an external force e.g. radios, cell phones, or unintentional disturbances of another device)		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91923	3287	ELECTRON MICROSCOPY		Inspection of objects or surfaces requiring magnification using an electron microscope.		C91965	3321	MICROSCOPIC INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91924	3288	ELECTROSTATIC DISCHARGE TESTING		Testing the device for malfunctions related to the transfer of an electrostatic charge (by direct contact or from electrostatic fields) between objects of different potentials.		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91925	3289	EMISSIONS TESTING		Testing the device for adequately controlled electromagnetic emissions.		C91922	3286	ELECTROMAGNETIC COMPATIBILITY (EMC) EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91926	3290	ENVIRONMENT EVALUATION		Evaluating devices for responses to physical characteristics in their surroundings.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91927	27	FATIGUE TESTING		Testing the device's capability to withstand the progressive and localized structural damage that occurs when a material is subjected to cyclic loading. This is a dynamic mechanical test for wear or fatigue.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91928	89	FLOW TESTING		Testing the device to assess the volume of fluid moving per unit of time. This may also include filter testing.		C91963	26	MECHANICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91929	3292	FLUID PRESSURE TESTING		Testing the fluid pressure (pressure at some point within a fluid e.g. water or air) within a device.		C91963	26	MECHANICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91930	3293	FRACTURE TOUGHNESS TESTING		Testing the device's ability to resist local separation into two, or more, pieces under the action of stress.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91931	13	DEVICE FROM CONTROLLED OR NON-RELEASED SAMPLE EVALUATED				C91897	3263	ACTUAL DEVICE NOT EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91932	12	DEVICE FROM RESERVE SAMPLE EVALUATED				C91897	3263	ACTUAL DEVICE NOT EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91933	11	DEVICE FROM SAME LOT EVALUATED				C91897	3263	ACTUAL DEVICE NOT EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91934	3294	GENOTOXIC TESTING		Testing the device's ability to cause damage to genetic material. (e.g., leading to outgrowths -- malignant tumors).		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91935	3295	GRADIENT-INDUCED FIELD EFFECT TESTING		Testing the RF shield around the coils of an MRI device for its ability to provide effective screening against electrical (eddy) currents induced by gradient switching.		C91982	3336	RADIOGRAPHIC INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91936	3296	GROWTH FACTOR EVALUATION		Evaluating a device's characteristics that may affect the self healing ability of an organism.		C92015	3364	TISSUE ENGINEERING EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91937	3297	HARDNESS TESTING		Testing the device's ability to resist deformation. Hardness is the property of a material that enables it to resist plastic deformation, usually by penetration. However, the term hardness may also refer to resistance to bending, scratching, abrasion or cutting. The usual method to achieve a hardness value is to measure the depth or area of an indentation left by an indenter of a specific shape, with a specific force applied for a specific time.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91938	3298	HEMATOLOGIC TESTING		Testing the device for its affect or impact on the blood or its components.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91939	82	HUMIDITY TESTING		Testing the device's protective materials to prevent moisture penetration or ingress.		C91926	3290	ENVIRONMENT EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91940	3299	IMAGE ARTIFACT TESTING		Testing an imaging device to determine the amount of distortion or signal loss (artifacts) produced in an image.		C91983	3337	RADIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91941	3300	IMAGE INSPECTION		Macroscopic inspection commonly used to describe physical objects that are measurable and observable by the naked eye.		C92023	38	VISUAL INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91942	3301	IMMUNITY TESTING		Testing the device for adequate immunity or capability to resist electromagnetic interference (EMI).		C91922	3286	ELECTROMAGNETIC COMPATIBILITY (EMC) EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91943	3302	IMPACT TESTING		Testing the device's response to a suddenly applied stress. The test ascertains whether the material is tough or brittle.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91944	3303	IMPEDANCE TESTING		Testing the resistance to current flow in a device's circuit or component.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91945	3304	IN SITU OBSERVATION		Observing the device in the exact same conditions and setting in which the device was used.		C92020	3367	USE TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91946	3305	INFRASOUND TESTING				C91898	3261	ACOUSTIC ENERGY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91947	3306	INGRESS PROTECTION TESTING		Testing the device's ability to protect against ingress or access of unwanted fluids or solids.		C91963	26	MECHANICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91948	3307	INSTALLATION REVIEW		Performing a review of the processes used to install a device and the records reflecting these processes performed for a specific device.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91949	3308	INSULATION TESTING		Testing the ability of a device's or component's material to resist the flow of electric current.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91950	3309	INTERFERENCE SUBSTANCE TESTING		A test used with in vitro diagnostic analytic systems to detect substances that may be interfering with test results and causing errors.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91951	20	INTEROPERABILITY EVALUATION		Testing devices for problems with the mechanical, electrical, or communication interface between two or more separate devices or components.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91952	3310	IONIZING RADIATION TESTING		Testing that ionizing radiation is delivered at the appropriate energy and dose to the appropriate region of interest for the exam or therapy under evaluation.		C91983	3337	RADIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91953	36	LABELING EVALUATION		Reviewing all labeling (including instructions for use, manuals, and packaging) for language related to reported device problems.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91954	3311	LIGHT SOURCE PERFORMANCE EVALUATION		Testing the optical properties of a device such as diopter, glare, and irradiance or glistening.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91955	3312	LIGHT TESTING		Testing the device's characteristics when subjected to variations of ambient light within its surroundings.		C91926	3290	ENVIRONMENT EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91956	3313	LINE VOLTAGE TESTING		Tests to determine whether a device's insulation has the strength to prevent any current from reaching the operator.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91957	3314	MAGNETICALLY-INDUCED DISPLACEMENT FORCE TESTING		Testing the static magnetic field gradients on medical imaging devices for their ability to move objects.		C91983	3337	RADIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91958	3315	MAGNETICALLY-INDUCED TORQUE TESTING		Testing the static magnetic field gradients on medical imaging devices for their ability to rotate objects.		C91983	3337	RADIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91959	3316	MAINTENANCE REVIEW		Performing a review the technical and corresponding administrative actions and records intended to retain an item in, or restore it to, a state in which it can perform its required function. This evaluation includes reviewing the user's maintenance procedures and processes as to whether they were followed.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91960	3317	MANUFACTURING REVIEW		Performing a review of the manufacturing steps and processes to ensure that they were met and followed and that the device records reflected these processes.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91961	3318	MATERIALS AND CHEMISTRY EVALUATION		Testing devices for malfunctions that arise from problems with its components or materials or how its materials or components react to other elements either within the device or within the environment.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91962	3319	MATERIAL OR MATERIAL LEACHATE PYROGENIC TESTING		Testing the device for the presence of unwanted agents (e.g. pyrogens) caused by materials that permeate through the device.		C91912	3277	CONTAMINATION TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91963	26	MECHANICAL EVALUATION		Testing the device for problems that result from external forces including fluids, other objects, or environmental or physiologic influences.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91964	3320	MICROBIAL CONTAMINATION TESTING		Testing the device for the presence of microorganisms such as bacteria, viruses, and fungi (yeasts and molds).		C91912	3277	CONTAMINATION TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91965	3321	MICROSCOPIC INSPECTION		Inspection of objects or surfaces requiring magnification using a microscope e.g. with electron, optical, or scanning probe microscopy.		C92023	38	VISUAL INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91966	3322	MUTAGENIC TESTING		Testing the device's ability to change genetic information (usually DNA) of an organism and thus increasing the frequency of mutations.		C91934	3294	GENOTOXIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91967	3323	NO TESTING METHODS PERFORMED		Testing was not performed on the device.		C91897	3263	ACTUAL DEVICE NOT EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91968	84	OPTICAL MICROSCOPY		Inspection of objects or surfaces requiring magnification using an optical microscope.		C91965	3321	MICROSCOPIC INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91969	3324	OVERCURRENT PROTECTION TESTING		Testing the device's over-current protection circuitry for its response to situations of overload, short circuit, or ground fault.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91970	3325	PACKAGING VERIFICATION		Verifying that the device packaging met proper sterilization conditions and that the effectiveness of the packaging kept the device free viable microorganisms.		C92002	3352	STERILIZATION PROCESS REVIEW
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91971	83	PATHOLOGICAL EXAMINATION		Examining material that may have contributed to the disease or damage. Often performed using a microscope by measuring structural changes that occur along with the disease or damage.		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91972	37	PHOTOGRAPHIC INSPECTION				C91941	3300	IMAGE INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91973	3326	PHYSICAL STRUCTURE TESTING		Testing the device for problems related to the incorrect or inadequate arrangement of the parts, components, elements, or materials.		C91961	3318	MATERIALS AND CHEMISTRY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91974	3327	PLATELET ACTIVATION TESTING		Testing the device for characteristics that lead to the activation of platelets which are essential to stop bleeding and repair the tissue. Platelets also play a key role in the development of acute coronary syndromes and contribute to cerebrovascular events.		C91938	3298	HEMATOLOGIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91975	3328	POWER FREQUENCY MAGNETIC FIELD TESTING		Tests performed to verify a device's level of protection (immunity) against magnetic disturbances while operating.		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91976	3329	POWER SOURCE TESTING		Testing the power sources in a device e.g., battery, internal power supply to detect any malfunction.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91977	3330	PRESSURE TESTING		Testing the device's characteristics when subjected to high or low pressure conditions.		C91926	3290	ENVIRONMENT EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91978	3331	PROCESS EVALUATION		Performing a review of the manufacturing and production processes and/or records for a specific device or lot that may have contributed to problems with a device.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91979	3332	QUALITY CONTROL REVIEW		Performing a review of the processes used in developing systems to ensure that products are designed and produced and services are developed to meet or exceed device specifications and customer expectations.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91980	3333	RADIATED EMISSIONS TESTING		Testing the ability of a device's radiated emissions to cause another device to fail (i.e. electromagnetic disturbance for which the energy is transferred through space in the form of electromagnetic waves).		C91925	3289	EMISSIONS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91981	3335	RADIOFREQUENCY INTERFERENCE TESTING		Testing the device to detect device malfunctions caused by a disturbance affecting an electrical circuit due to electromagnetic radiation emitted from an external source. This includes susceptibility to interference via cables or air.		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91982	3336	RADIOGRAPHIC INSPECTION				C91941	3300	IMAGE INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91983	3337	RADIOLOGIC EVALUATION		Evaluating the safety provisions in a device used for medical imaging, i.e., if the device can cause injury to individuals during imaging process (visualizing the structure and function of the body).		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91984	3338	REACTIVITY TESTING		Testing the device for problems related to how the materials react to other factors (e.g. over-react or under-react).		C91961	3318	MATERIALS AND CHEMISTRY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91985	3339	REPRODUCTIVE TOXICITY EVALUATION		Evaluating a device for chemicals or other agents that may have caused problems with the reproductive system. This includes evaluating a device for chemicals or agents that may have caused or contributed to birth defects or malformations (teratogenic evaluation).		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91986	95	RESERVE SAMPLE FROM DIFFERENT LOT TESTED, NO FAILURE DETECTED				C91932	12	DEVICE FROM RESERVE SAMPLE EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91987	3340	RESERVE SAMPLE TESTED FROM SAME LOT, NO FAILURE DETECTED				C91932	12	DEVICE FROM RESERVE SAMPLE EVALUATED
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91988	3341	RADIOFREQUENCY INDUCED HEAT TESTING		Testing the static magnetic field gradients on medical imaging devices for their ability to induce heat in objects.		C91983	3337	RADIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91989	3342	SCAFFOLD EVALUATION		Evaluating a device's characteristics for its affects on the reproduction of tissues.		C92015	3364	TISSUE ENGINEERING EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91990	3343	SCANNING PROBE MICROSCOPY		Inspection of objects or surfaces requiring magnification using a scanning probe microscope.		C91965	3321	MICROSCOPIC INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91991	3344	SHOCK TESTING		Examining a device for problems resulting from transient physical insults such as dropping or shaking the device.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91992	3345	SIMULATED USE TESTING		Testing the devices in situations that mimic real life settings but do not involve patients.		C92020	3367	USE TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91993	22	SOFTWARE EVALUATION				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91994	3346	SOFTWARE STRESS TESTING		Tests conducted to evaluate a software application at or beyond the limits of its specified requirements.		C91996	3348	SOFTWARE VERIFICATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91995	3347	SOFTWARE VALIDATION		Validating that a system or component during or at the end of the development process satisfies specified requirements (the process may include algorithm evaluation).		C91993	22	SOFTWARE EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91996	3348	SOFTWARE VERIFICATION		A process used to verify that a system or component performs according to the original set of conditions at any point in development.		C91993	22	SOFTWARE EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91997	3273	CODE REVIEW		A systematic review of source code intended to find and fix mistakes possibly overlooked in the initial development phase.		C91993	22	SOFTWARE EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91998	3272	CODE VALIDATION		Ensuring that common error patterns and violations of best practices in coding have been followed.		C91995	3347	SOFTWARE VALIDATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C91999	3349	SPECTROSCOPY		Testing the device using a spectrometer or spectrograph for the dispersion of visible light (includes electromagnetic, electron, and acoustic spectroscopy).		C92023	38	VISUAL INSPECTION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92000	3350	STATIC ANALYSIS		The process of analyzing the software code without running it. For example, formal verification, which is proving or disproving the correctness of intended algorithms underlying a system with respect to a certain formal specification or property using formal methods of mathematics e.g. model checking, theorem proving, symbolic verification).		C91996	3348	SOFTWARE VERIFICATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92001	3351	STERILITY METHOD VERIFICATION		Verifying that the methods used to free a medical device from viable microorganisms such as fungi, bacteria, and viruses were followed.		C92002	3352	STERILIZATION PROCESS REVIEW
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92002	3352	STERILIZATION PROCESS REVIEW		Performing a review of the records and processes used to render a product free from viable microorganisms.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92003	3353	STORAGE AND SHIPMENT REVIEW		Performing a review of the storage and shipping processes and requirements.		C91978	3331	PROCESS EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92004	3354	STRENGTH TESTING		Testing the device's ability to resist forces that attempt to break or deform the device. This evaluation includes testing tension such as pull testing.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92005	3355	STRESS TESTING		Testing the device for failures caused by applying force per unit area. This test includes durability testing.		C91963	26	MECHANICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92006	39	DEVICE STRUCTURE TESTING		Testing devices for problems related to the presence of an inappropriate molecular geometry somewhere in the device (i.e., the spatial arrangement of atoms in a molecule and the chemical bonds that hold the atoms together).		C91961	3318	MATERIALS AND CHEMISTRY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92007	3356	SURGE PROTECTION TESTING		Testing the device's ability to protect itself of other devices against sudden bursts of current or voltage.		C91942	3301	IMMUNITY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92008	3357	SURGE RESPONSE TESTING		Testing for a response to a transient electrical current or voltage.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92009	3358	SYSTEM TESTING		Tests conducted on a complete, integrated system to evaluate the system's compliance with its specified requirements.		C91996	3348	SOFTWARE VERIFICATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92010	3359	TEMPERATURE TESTING		Testing the device's characteristics when subjected to temperature change (cycling), and high or low temperatures.		C91926	3290	ENVIRONMENT EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92011	3360	TEST FOR HIGH TEMPERATURE CONDITIONS				C92013	3362	THERMAL ENERGY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92012	3361	TEST FOR LOW TEMPERATURE CONDITIONS				C92013	3362	THERMAL ENERGY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92013	3362	THERMAL ENERGY EVALUATION		Testing the device for conditions related to extremes of temperature.		C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92014	3363	THROMBOTIC TESTING		Testing the device for characteristics related to forming blood clots along the walls of blood vessels which can cause blockages and affect blood flow through vessels.		C91938	3298	HEMATOLOGIC TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92015	3364	TISSUE ENGINEERING EVALUATION		Evaluating a device's characteristics that may affect tissues (e.g. bone, cartilage, blood vessels, bladder).		C91905	3269	BIOLOGIC EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92016	34	DEVICE-TO-DEVICE INTERACTION TESTING		Tests conducted to assess the mechanical, electrical, or electronic compatibility of two or more devices.		C91951	20	INTEROPERABILITY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92017	35	DEVICE-TO-HUMAN INTERACTION TESTING		Tests conducted to assess the interaction between a device and the user		C91951	20	INTEROPERABILITY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92018	3365	ULTRASONIC SOUND TESTING		Testing the devices response to variations in air pressure for detecting sound with frequencies greater than upper limit of human hearing (> 20 kHz).		C91898	3261	ACOUSTIC ENERGY TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92019	3366	UNIT TESTING		Testing of individual hardware or software components or groups of related units.		C91996	3348	SOFTWARE VERIFICATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92020	3367	USE TESTING		Any testing performed that simulates real use situations experienced by users.		C91951	20	INTEROPERABILITY EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92021	3368	USER SURVEY		Questioning a pre-defined group of users about their practices.		C92020	3367	USE TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92022	3369	VIBRATION TESTING		Evaluating a device for problems resulting from periodic or random mechanical oscillations which could induce damage.		C92005	3355	STRESS TESTING
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92023	38	VISUAL INSPECTION				C54028	3291	EVALUATION METHOD
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92024	3370	VOLTAGE FLUCTUATION TESTING		Testing the device for its immunity when subjected to positive and negative low amplitude voltage fluctuations.		C91919	23	ELECTRICAL EVALUATION
N	FDA	C91800	Medical Device Evaluation Methods Terminology FDA CDRH	C92025	3371	WEAR TESTING		Examining a device for signs of unexpected erosion on its surface or other components or parts.		C92005	3355	STRESS TESTING
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C54029	3249	EVALUATION RESULT				C62596		
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92026	3202	AGGLUTINATION		The device affects the ability of the blood to clot which may be induced by chemical, mechanical, or thermal properties of the device.		C92060	3255	HEMATOLOGIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92027	635	ARITHMETIC ERROR		The device software performed an incorrect arithmetic operation.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92028	706	ASSEMBLY PROBLEM		A device problem that occurred because the device was assembled or put together incorrectly.		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92029	3203	BIOCOMPATIBILITY PROBLEM		The device causes cellular or tissue responses that elicit an undesirable local or systemic effect in the recipient or beneficiary of that therapy (see ISO 10993).		C92030	3204	BIOLOGICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92030	3204	BIOLOGICAL PROBLEM				C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92031	3205	CARCINOGENIC PROBLEM		The device's ability to promote cancer or facilitate its propagation.		C92057	3254	GENOTOXIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92032	3209	DAMAGE DUE TO CHEMICAL AGENT		A device that experienced damage as the result of a chemical agent used during the sterilization process e.g. excessive residual chemical or an incompatible sterilant.		C92033	201	CLEANING, DISINFECTING AND STERILIZATION PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92033	201	CLEANING, DISINFECTING AND STERILIZATION PROBLEM		A device problem that occurred during or as the result of the cleaning, disinfecting, or sterilizing process.		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92034	628	COMMUNICATIONS PROBLEM		Devices that do not send or receive adequate signals (this speaks to the interoperability between devices).		C92070	3213	INTEROPERABILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92035	3206	COMPLEMENT ACTIVATION		The device interferes with an organism's ability to clear pathogens which may be caused by an interaction with chemicals or materials.		C92060	3255	HEMATOLOGIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92036	3207	COMPONENT MIGRATION		A device or a component of a device that has moved from its original location due to external forces (e.g. stent or lead movement).		C92079	180	MECHANICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92037	658	CONDUCTED INTERFERENCE		A device that experienced electromagnetic interference (EMI) by physical contact with conductors (e.g. wires, resistors, terminals) as opposed to radiated EMI which is caused by induction (without physical contact of the conductors).		C92046	197	ELECTROMAGNETIC COMPATIBILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92038	3208	CONFIGURATION ISSUE		Device problems due to incorrect version or change control.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92039	663	DATA COMPRESSION ERROR		Data was lost or corrupted during the operation of reducing storage space or communication bandwidth.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92040	3211	DEFORMATION PROBLEM		Device problems caused by changes in the shape or size of the device or device component due to an applied force. This can be a result of tensile forces, compressive forces, shear, bending, tensile (pulling), or torsion.		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92041	135	DEGRADATION PROBLEM		Device problems that occur when the device becomes worn, weakened, corroded, or broken down due to processes such as aging, permeation, and corrosion.		C92078	174	MATERIALS AND CHEMISTRY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92042	110	DESIGN ERROR		The device or component had faulty (incomplete or incorrect) software design.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92043	646	DUST OR DIRT PROBLEM		A device that experienced problems due to dust or dirt that has adhered to its surfaces.		C92051	331	ENVIRONMENT PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92044	650	CURRENT LEAKAGE PROBLEM		A device that experiences problems related to small currents which may cause electric shock. Leakage current is the current that flows through the protective ground conductor to ground. In the absence of a grounding connection, it is the current that could flow from any conductive part or the surface of non-conductive parts to ground if a conductive path was available (such as a human body). There are always extraneous currents flowing in the safety ground conductor.		C92097	3227	POWER SOURCE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92045	120	ELECTRICAL PROBLEM				C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92046	197	ELECTROMAGNETIC COMPATIBILITY PROBLEM		A device-to-device or device-environment problem resulting from electromagnetic disturbances		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92047	648	ELECTROSTATIC DISCHARGE		A device that experienced problems due to sudden and momentary bursts of electrical current flowing between 2 objects at different electrical potentials.		C92046	197	ELECTROMAGNETIC COMPATIBILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92048	133	END OF LIFE PROBLEM		Device problems that occur from its reaching the end of its useful life.		C92088	114	OPERATIONAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92049	3212	ENDOTOXIN CONTAMINATION		The undesirable presence of toxins associated with certain bacteria (e.g. gram negative bacteria).		C92054	142	CONTAMINATION BY FOREIGN MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92050	131	ENERGY STORAGE SYSTEM PROBLEM		Device problems related to the energy storage system (e.g. the rechargeable battery, charging system, or capacitor) and includes problems such as premature power source depletion and battery explosions. An accumulator is an apparatus by means of which energy can be stored, such as a rechargeable battery or a hydraulic accumulator. Such devices may be electrical, fluidic or mechanical and are sometimes used to convert a small continuous power source into a short surge of energy or vice versa. Other examples of accumulators include capacitors, compulsators, steam accumulator, wave energy machines, pumped-storage hydroelectric plants.		C92097	3227	POWER SOURCE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92051	331	ENVIRONMENT PROBLEM		A device problem that occurred due to factors within the environment e.g. dust, dirt, humidity, temperature.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92052	3250	FAILURE TO CALIBRATE		A device that cannot calibrate (establish the relationship between a measuring device and the units of measure) to ensure accurate readings.		C92088	114	OPERATIONAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92053	3251	FATIGUE PROBLEM		Device problems due to the weakening or breakdown of its material when subjected to stress or a series of repeated stresses.		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92054	142	CONTAMINATION BY FOREIGN MATERIAL		The undesirable presence of any substance that does not belong either on the device or in an organism and may lead to infection or fever.		C92030	3204	BIOLOGICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92055	3252	FRACTURE PROBLEM		Device problems caused by the separation of a component, object, or material into two or more pieces including shear.		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92056	3253	FRICTION PROBLEM		A device problem caused by its surface coming in contact with another surface or fluid.		C92079	180	MECHANICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92057	3254	GENOTOXIC PROBLEM		The device's ability to cause damage to genetic material (e.g., leading malignant tumors). (See ISO 10993)		C92030	3204	BIOLOGICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92058	323	GRADIENT INDUCED FIELD PROBLEM		Device problems that result from the gradient induced fields generated during radiologic procedures e.g. magnetic resonance imaging.		C92102	3230	RADIOGRAPHIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92059	211	HARDWARE TIMING PROBLEM		A problem that results from improper sequencing or activation of electronic components.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92060	3255	HEMATOLOGIC PROBLEM		The device affects or impacts the blood or its components. (See ISO 10993)		C92030	3204	BIOLOGICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92061	332	IMPROPER HUMIDITY		A device that malfunctions as the result of exposure to undesirable levels of humidity		C92051	331	ENVIRONMENT PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92062	3256	IMAGE ARTIFACT		The unacceptable distortion of an image due to signal loss that may occur during a radiologic procedure such as magnetic resonance imaging.		C92102	3230	RADIOGRAPHIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92063	3257	IMPEDANCE PROBLEM		A device that experienced problems due to insufficient or excessive resistance to AC current flow either by the device or circuit.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92064	3258	IMPROPER COMPOSITION/CONCENTRATION		Device problems associated with the improper combination of materials or elements present in the device (e.g., improper composition of the materials of a capacitor).		C92065	202	IMPROPER MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92065	202	IMPROPER MATERIAL		Device problems that occur due to the presence of a material that should not be present or part of the device.		C92078	174	MATERIALS AND CHEMISTRY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92066	102	INCOMPATIBLE COMPONENT		A device that malfunctions due to a component(s) that does not operate correctly and according to the device's specifications.		C92070	3213	INTEROPERABILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92067	3201	INSTALLATION PROBLEM		A device that malfunctions because it was incorrectly installed, set-up, or configured (e.g., misconfiguration of an automatic defibrillator to semi-automatic leading to failure)		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92068	144	INSULATION PROBLEM		A device that has inadequate or incorrect insulation material.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92069	113	INTERFACE DESIGN ERROR		The device software was found to contain errors in the user interface (including usability problems) or the interfaces with other systems.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92070	3213	INTEROPERABILITY PROBLEM		A problem with the mechanical, electrical, or communication interface between two or more separate devices or components.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92071	150	LABELING PROBLEM		Insufficient, inadequate, or incorrect information provided on a device's label or documentation regarding e.g. as the intended use, directions for use, and characteristics of the device.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92072	610	LOSS OF POWER		A device that experienced problems due to a loss in the power supply.		C92097	3227	POWER SOURCE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92073	145	LUBRICATION PROBLEM		A device problem that occurred because of the presence of either too much or too little lubricant where required (e.g., connectors, leading to failure mechanisms such as corrosion).		C92079	180	MECHANICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92074	3215	MAGNETICALLY-INDUCED TORQUE		Problems due to excessive torque created by the application of magnetic fields.		C92102	3230	RADIOGRAPHIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92075	115	MAINTENANCE PROBLEM		A device malfunction or problem that occurs because the device was not properly maintained according to the instructions (e.g., maintenance may be performed by user facility, distributor, or service provider).		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92076	170	MANUFACTURING PROCESS PROBLEM		Problems with a device that can be traced back to a problem in the manufacturing and/or production process.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92077	3216	MATERIAL OR MATERIAL LEACHATE PYROGENIC PROBLEM		The undesirable presence of pyrogens or fever-producing organisms caused by materials that permeate through the device.		C92054	142	CONTAMINATION BY FOREIGN MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92078	174	MATERIALS AND CHEMISTRY PROBLEM		Device malfunctions that arise from problems with its components or materials or how its materials or components react to other elements either within the device or within the environment.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92079	180	MECHANICAL PROBLEM		Device problems that result from internal or external forces including fluids, other objects, or environmental or physiologic influences.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92080	3217	MECHANICAL SHOCK PROBLEM		Device problems caused by the sudden violent blow or collision to the whole device (e.g. by dropping).		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92081	3218	MICROBIAL CONTAMINATION		The undesirable presence of microorganisms or microbes such as bacteria and fungi (yeasts and molds).		C92054	142	CONTAMINATION BY FOREIGN MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92082	3220	MUTAGENIC PROBLEM		The device's ability to change genetic information (usually DNA) of an organism and thus increasing the frequency of mutations.		C92057	3254	GENOTOXIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92083	213	NO FAILURE DETECTED		The device either functioned as designed or a failure was not found.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92084	3221	NO RESULTS AVAILABLE SINCE NO EVALUATION PERFORMED		For use when no methods were performed and therefore no results will be obtained.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92085	3222	NON-FUNCTIONAL DEFECT		The device software contained software errors that did not impact its operation.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92086	3223	NON-TERMINATING CODE		The device software failed to provide a safe exit from a repeating code segment.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92087	122	OPEN CIRCUIT		A device with an electrical circuit that does not conduct current because a switch is open, a wire is broken, etc.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92088	114	OPERATIONAL PROBLEM		Device problems that occur during the performance, use, or functioning of the device.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92089	3224	OPTICAL PROBLEM				C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92090	196	OPTICAL TRANSMISSION PROBLEM		A problem with the device's ability to pass light energy.		C92089	3224	OPTICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92091	3225	OUT-OF-BOUNDS ERROR		The device software attempted to write data outside the allowed memory location.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92092	160	PACKAGE INSERT PROBLEM		Device packaging that is missing the insert or that contains an incorrect or inadequate insert (e.g. an insert with either the incorrect information or insufficient information).		C92094	111	PACKAGING PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92093	171	PACKAGING COMPROMISED		Device packaging that has been opened purposefully or inadvertently thus exposing the device to the outside environment and rendering it unsterile or unclean (e.g. a broken seal or ripped or torn packaging).		C92094	111	PACKAGING PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92094	111	PACKAGING PROBLEM		Reports related to the outer, protective wrapping of a device (e.g. a broken seal or ripping (compromised), lack of correct contents).		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92095	3226	PLATELET ACTIVATION PROBLEM		A device that affects the body's ability to activate platelets which are essential to stop bleeding and repair the tissue. Platelets also play a key role in the development of acute coronary syndromes and contribute to cerebrovascular events.		C92060	3255	HEMATOLOGIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92096	659	POWER FLUCTUATION		The device or component failed due to fluctuations within the power supply (e.g. transient power, power spike, power dip, or power sequencing).		C92097	3227	POWER SOURCE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92097	3227	POWER SOURCE PROBLEM		Problems that are related to the device that provides power.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92098	3228	PROTECTIVE SYSTEM FAILURE		A device that fails when the system designed to ensure its safe operation fails.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92099	143	QUALITY CONTROL PROBLEM		Device problems that result from the failure to maintain or establish techniques for controlling and verifying the product specifications identified by the manufacturer.		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92100	3229	RADIOFREQUENCY INDUCED OVERHEATING		An unacceptable or unexpected RF-induced temperature rise in the vicinity of a medical device or body part (usually caused by a closed current loop).		C92102	3230	RADIOGRAPHIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92101	611	RADIOFREQUENCY INTERFERENCE (RFI)		A device that experienced problems due to radiofrequency interference. RFI is a disturbance that affects an electrical circuit due to either electromagnetic conduction or electromagnetic radiation emitted from an external source.		C92046	197	ELECTROMAGNETIC COMPATIBILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92102	3230	RADIOGRAPHIC PROBLEM		Problems that occur with devices used for radiographic or imaging procedures e.g. CT scanners, magnetic resonance imaging, etc.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92103	3231	REACTIVITY PROBLEM		A device problem related to how the materials react inappropriately (e.g. over-react or under-react).		C92078	174	MATERIALS AND CHEMISTRY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92104	3232	REPRODUCTIVE TOXICITY PROBLEM		The device or component affects reproductive function, embryo development (teratogenicity), and prenatal and early postnatal development. (ISO 10993 part 3)		C92030	3204	BIOLOGICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92105	3235	RUNTIME MEMORY ACCESS ERROR		The device software attempted to access an illegal or corrupted memory location.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92106	192	SHELF LIFE EXCEEDED		A device that has exceeded the period of time recommended by the manufacturer for storing the device without a degradation in quality.		C92088	114	OPERATIONAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92107	3236	SHIPPING PROBLEM		Device problems traced back to how the device was shipped (some examples may include the temperature of the shipping compartment or the method of transportation).		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92108	121	SHORT CIRCUIT		A device experiencing problems due to an unintentionally low-resistance connection between two points in an electric circuit, resulting in either excessive current flow that often causes damage or in a new shorter circuit that draws current away from the original pathways and components.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92109	3237	SIGNAL LOSS		Problems with a device due the loss or weakening of a signal or signals.		C92045	120	ELECTRICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92110	3210	DEADLOCK		The device software locked up because two or more processes were waiting for each other to finish.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92111	3238	SOFTWARE INSTALLATION PROBLEM		The device software was not installed as per the specifications or failed to properly install.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92112	3214	LIVELOCK		The device software failed because two or more processes compete with each other such that the program does not perform as intended.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92113	104	SOFTWARE PROBLEM				C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92114	3239	SOFTWARE REQUIREMENT ERROR		The software requirements for the device are either incomplete, inadequate, or in conflict.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92115	3240	SOFTWARE RUNTIME ERROR		The device software failed during operation as a result of a coding error.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92116	3241	SOFTWARE SECURITY VULNERABILITY		The device software failed to provide adequate authorization, access control, and accountability features.		C92113	104	SOFTWARE PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92117	634	SOFTWARE TIMING PROBLEM		A device problem that results from the incorrect sequencing or activation of software modules.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92118	3242	STIFFNESS PROBLEM		A device problem that occurred when its material is either too flexible/pliable or inflexible/rigid when in contact by an applied force.		C92079	180	MECHANICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92119	193	STORAGE PROBLEM		Device problems that result from storing the device in an uncontrolled or improper environment (e.g., moisture sensitive devices stored in a humid environment).		C92076	170	MANUFACTURING PROCESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92120	3243	STRESS PROBLEM		Device problems caused by either excessive or inadequate physical force exerted on it by another object resulting in problems e.g. wear, bending, deformation, fracture, fatigue.		C92079	180	MECHANICAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92121	3219	MOLECULAR STRUCTURE PROBLEM		Device problems related to the presence of an inappropriate molecular geometry somewhere in the device (i.e., the spatial arrangement of atoms in a molecule and the chemical bonds that hold the atoms together).		C92065	202	IMPROPER MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92122	642	THERMAL PROBLEM		Device problems related to the temperature of the component, device or use environment.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92123	3244	THROMBOSIS ACTIVATION PROBLEM		The device or component caused the formation of a stationary blood clot along the walls of a blood vessel resulting in an obstruction. The obstruction can occur by several means e.g. blood clotting problems (coagulation), clots from other areas of the body (emboli), or caused by device materials or reactions to drugs or the removal of drugs.		C92060	3255	HEMATOLOGIC PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92124	176	TOLERANCE STACK-UP		Device problems that result from a combination of specification variances of the components.		C92088	114	OPERATIONAL PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92125	3245	TYPE MISMATCH		The device software assigned one type of value into a variable of another type.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92126	637	UNHANDLED INTERRUPT OR EXCEPTION		The device software did not correctly address abnormal execution of the code.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92127	3246	UNREACHABLE CODE		The device software contained code that could never be executed under any circumstance.		C92115	3240	SOFTWARE RUNTIME ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92128	3247	UNUSED DEVICE RETURNED IN STERILE PACKAGING		An unused device that has been returned in packaging that remains intact.		C92094	111	PACKAGING PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92129	649	VIBRATION PROBLEM		Device problems caused by the constant rhythmic motion of the device, a device's component, or something in the environment to which the device is exposed.		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92130	140	WEAR PROBLEM		Device problems due to the premature or expected erosion of its material by use, deterioration, or change.		C92120	3243	STRESS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92131	608	WIRED COMMUNICATION PROBLEM		Communications problems between devices within a wired system.		C92034	628	COMMUNICATIONS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92132	3248	WIRELESS COMMUNICATION PROBLEM		Communications problems between devices within a wireless system.		C92034	628	COMMUNICATIONS PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92133	3259	IMPROPER PHYSICAL STRUCTURE		A device problem related to the incorrect or inadequate arrangement of the parts, components, elements, or materials.		C92065	202	IMPROPER MATERIAL
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92134	651	IMPROPER TEMPERATURE		A device that malfunctions as the result of exposure to the temperatures that are outside of those in the device's specifications.		C92051	331	ENVIRONMENT PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92135	3260	INADEQUATE IMMUNITY		A device that lacks adequate immunity or capabilities to resist electromagnetic interference (EMI).		C92046	197	ELECTROMAGNETIC COMPATIBILITY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92136	156	INADEQUATE LABELING CONTENT		Invalid, incorrect, or inappropriate information on the labels (not including instructions for use) e.g. mislabeled contents or device labeling characteristics or package contents.		C92071	150	LABELING PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92137	154	INADEQUATE INSTRUCTIONS FOR USE		Insufficient information on the labels or in the manuals related to a device's instructions for use e.g. steps that are difficult to follow or that are missing.		C92071	150	LABELING PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92138	195	INAPPROPRIATE OR INSUFFICIENT STERILIZATION		Inadequate sterilization of a device possibly resulting in the presence of microorganisms or other contaminants on the device.		C92033	201	CLEANING, DISINFECTING AND STERILIZATION PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92139	203	INCOMPATIBLE MATERIAL		Device problems related to materials that can co-exist simultaneously as part of the device.		C92078	174	MATERIALS AND CHEMISTRY PROBLEM
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92140	3199	INCOMPLETE DEVICE RETURNED		The device that was returned was not complete and/or is missing parts or components.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92141	3200	INCORRECT DATA DEFINITION		The device software was found to contain errors in specifying or manipulating data items.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92142	618	INCORRECT ALGORITHM		The device software was found to implement an incorrect sequence of steps for a specific computation.		C92042	110	DESIGN ERROR
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92143	3233	RESULTS PENDING COMPLETION OF EVALUATION		For use when the evaluation is still in progress.		C54029	3249	EVALUATION RESULT
N	FDA	C91801	Medical Device Evaluation Results Terminology FDA CDRH	C92144	3234	REUSED DEVICE NOT CLEANED		A device that has been used more than once without being cleaned according to the device's cleaning instructions.		C92033	201	CLEANING, DISINFECTING AND STERILIZATION PROBLEM
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C54030	17	EVALUATION CONCLUSION				C62596		
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91867	10	CANNOT COMPLETE INVESTIGATION, INCOMPLETE DEVICE RETURNED				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91868	11	CONCLUSION NOT YET AVAILABLE-EVALUATION IN PROGRESS		The device is undergoing an evaluation but has not yet been completed.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91869	12	DESIGN DEFICIENCY		The device problem was traced back to the design specifications (e.g. in the requirements, testing processes, hazard analysis, implementation strategy).		C91885	25	QUALITY SYSTEM DEFICIENCY
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91870	13	DEVICE DIFFICULT TO OPERATE		Device problems including set-up, operation, and disassembly of equipment.		C91874	19	HUMAN FACTORS ISSUE
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91871	70	DEVICE DISCARDED BY USER, UNABLE TO FOLLOW-UP				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91872	50	DEVICE FAILURE RELATED TO PATIENT CONDITION		A device problem that occurred in part or in total related to the patient's physiology.		C91874	19	HUMAN FACTORS ISSUE
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91873	18	FAILURE TO FOLLOW INSTRUCTIONS		A device problem related to the user not following the manufacturer's instructions.		C91874	19	HUMAN FACTORS ISSUE
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91874	19	HUMAN FACTORS ISSUE				C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91875	20	INCONCLUSIVE-INVESTIGATION IN PROGRESS				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91876	14	DEVICE INCORRECTLY PREPARED FOR USE OR MODIFIED		A device that is incorrectly modified or prepared for use by distributor, service provider, or user facility.		C91874	19	HUMAN FACTORS ISSUE
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91877	21	INFRASTRUCTURE FAILURE		Device problems related to problems with the underlying framework, systems, and processes of an organization (e.g. as building power supply, network, oxygen systems).		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91878	22	KNOWN INHERENT RISK OF PROCEDURE		Device problems known and documented in the labeling (including both short or long term known complications or adverse reactions).		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91879	57	LABELING DEFICIENCY		Device problems that occur as the result of problems with the labeling (including package inserts, instruction manuals, instructions for use).		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91880	51	MAINTENANCE DEFICIENCY		Device problems that result from improper routine or preventative maintenance.		C91885	25	QUALITY SYSTEM DEFICIENCY
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91881	23	MANUFACTURING DEFICIENCY		The device problem was traced back to the manufacture of the device as opposed to systems used to control the manufacture of the device (quality system). Examples include problems with construction or assembly.		C91885	25	QUALITY SYSTEM DEFICIENCY
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91882	15	DEVICE NOT MANUFACTURED BY REPORTING FIRM				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91883	92	DEVICE NOT RETURNED				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91884	77	OPERATIONAL CONTEXT CAUSED OR CONTRIBUTED TO EVENT		A device problem related to the operator's technique or use environment.		C91874	19	HUMAN FACTORS ISSUE
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91885	25	QUALITY SYSTEM DEFICIENCY		A defect in the processes or systems used in the design and manufacture of the device. Examples include problems within the change control, production, or quality control processes.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91886	94	DEVICE RECEIVED IN CONDITION MAKING EVALUATION IMPOSSIBLE				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91887	16	DEVICE RECEIVED UNUSED IN ORIGINAL PACKAGE				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91888	63	DEVICE REPAIRED AND RETURNED		The device was repaired and returned to the user (reporter) following a reported device problem.		C91885	25	QUALITY SYSTEM DEFICIENCY
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91889	27	TRAINING DEFICIENCY		A device problem related to inadequate training.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91890	71	NO FAILURE DETECTED, DEVICE OPERATED WITHIN SPECIFICATION				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91891	75	NO FAILURE DETECTED, DEVICE OUT OF SPECIFICATION				C91894	67	UNABLE TO CONFIRM COMPLAINT
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91892	24	OFF-LABEL, UNAPPROVED, OR CONTRAINDICATED USE		Device problems related to its use during an unapproved procedure, in an unapproved patient, or for which it is contraindicated, or not listed on the label.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91893	26	REUSE OF SINGLE USE DEVICE		Device problems related to the use of a device more than once when it is designed for only one use.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91894	67	UNABLE TO CONFIRM COMPLAINT		The device complaint or problem cannot be confirmed. If possible, choose a more specific reason from among the terms listed in this branch of the hierarchy.		C54030	17	EVALUATION CONCLUSION
N	FDA	C91802	Medical Device Evaluation Conclusions Terminology FDA CDRH	C91895	61	USE ERROR CAUSED OR CONTRIBUTED TO EVENT		The interaction between the device and the user caused or contributed to the error. This includes inappropriate use of the device or failure to appropriately maintain the device.		C91874	19	HUMAN FACTORS ISSUE